BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 23487783)

  • 1. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix.
    Martino MM; Briquez PS; Ranga A; Lutolf MP; Hubbell JA
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4563-8. PubMed ID: 23487783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain.
    Martino MM; Hubbell JA
    FASEB J; 2010 Dec; 24(12):4711-21. PubMed ID: 20671107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing.
    Ishihara J; Ishihara A; Fukunaga K; Sasaki K; White MJV; Briquez PS; Hubbell JA
    Nat Commun; 2018 Jun; 9(1):2163. PubMed ID: 29867149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing.
    Ishihara J; Ishihara A; Starke RD; Peghaire CR; Smith KE; McKinnon TAJ; Tabata Y; Sasaki K; White MJV; Fukunaga K; Laffan MA; Lutolf MP; Randi AM; Hubbell JA
    Blood; 2019 Jun; 133(24):2559-2569. PubMed ID: 30975637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing.
    Martino MM; Briquez PS; Güç E; Tortelli F; Kilarski WW; Metzger S; Rice JJ; Kuhn GA; Müller R; Swartz MA; Hubbell JA
    Science; 2014 Feb; 343(6173):885-8. PubMed ID: 24558160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site.
    Makogonenko E; Tsurupa G; Ingham K; Medved L
    Biochemistry; 2002 Jun; 41(25):7907-13. PubMed ID: 12069579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-like particles dynamically stiffen fibrin matrices and improve wound healing outcomes.
    Nandi S; Sproul EP; Nellenbach K; Erb M; Gaffney L; Freytes DO; Brown AC
    Biomater Sci; 2019 Jan; 7(2):669-682. PubMed ID: 30608063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen and fibrin.
    Weisel JW
    Adv Protein Chem; 2005; 70():247-99. PubMed ID: 15837518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin as a delivery system in wound healing tissue engineering applications.
    Whelan D; Caplice NM; Clover AJ
    J Control Release; 2014 Dec; 196():1-8. PubMed ID: 25284479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ sequestration of endogenous PDGF-BB with an ECM-mimetic sponge for accelerated wound healing.
    Li Q; Niu Y; Diao H; Wang L; Chen X; Wang Y; Dong L; Wang C
    Biomaterials; 2017 Dec; 148():54-68. PubMed ID: 28964982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix analogs as carriers for growth factors: in vitro fibroblast behavior.
    Roy F; DeBlois C; Doillon CJ
    J Biomed Mater Res; 1993 Mar; 27(3):389-97. PubMed ID: 8360207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coaxial nanofibrous scaffolds mimicking the extracellular matrix transition in the wound healing process promoting skin regeneration through enhancing immunomodulation.
    Sun L; Li J; Gao W; Shi M; Tang F; Fu X; Chen X
    J Mater Chem B; 2021 Feb; 9(5):1395-1405. PubMed ID: 33462572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosaminoglycans restrained in a fibrin matrix improve ECM remodelling by endothelial cells grown for vascular tissue engineering.
    Divya P; Krishnan LK
    J Tissue Eng Regen Med; 2009 Jul; 3(5):377-88. PubMed ID: 19452443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and in vivo evaluation of cationic elastic liposomes comprising highly skin-permeable growth factors combined with hyaluronic acid for enhanced diabetic wound-healing therapy.
    Choi JU; Lee SW; Pangeni R; Byun Y; Yoon IS; Park JW
    Acta Biomater; 2017 Jul; 57():197-215. PubMed ID: 28476587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin structure and wound healing.
    Laurens N; Koolwijk P; de Maat MP
    J Thromb Haemost; 2006 May; 4(5):932-9. PubMed ID: 16689737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin-based scaffold incorporating VEGF- and bFGF-loaded nanoparticles stimulates wound healing in diabetic mice.
    Losi P; Briganti E; Errico C; Lisella A; Sanguinetti E; Chiellini F; Soldani G
    Acta Biomater; 2013 Aug; 9(8):7814-21. PubMed ID: 23603001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Injectable Fibrin Scaffold Rich in Growth Factors for Skin Repair.
    Shao Z; Lyu C; Teng L; Xie X; Sun J; Zou D; Lu J
    Biomed Res Int; 2021; 2021():8094932. PubMed ID: 33628814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional peptide of dermatopontin produces fibrinogen fibrils and modifies its biological activity.
    Wu W; Okamoto O; Kato A; Matsuo N; Kumai J; Nomizu M; Fujiwara S
    J Dermatol Sci; 2014 Oct; 76(1):34-43. PubMed ID: 25082449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor binds to fibronectin through the type I repeat modules and enhances the affinity of fibronectin to fibrin.
    Yoshida K; Munakata H
    Biochim Biophys Acta; 2007 Apr; 1770(4):672-80. PubMed ID: 17239539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix.
    Han D; Liu W; Ao Q; Wang G
    Med Hypotheses; 2008 Sep; 71(3):374-8. PubMed ID: 18565684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.